Dabrafenib is mainly used for the treatment of unresectable or metastatic melanoma caused by a defect in the BRAF gene. Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.
White or slight colour solid
Off white solid
Loss on drying
Welcome to inquiry us to get the complete COA of Dabrafenib!
|Appearance:||White to slight colour solid|
|Package details:||1kg/bag with foil bag;25kg/drum|
Guaranteed the purity
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!